Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 18

    1.

    Pediatric melanomas and the atypical spitzoid melanocytic neoplasms.

    Hill SJ, Delman KA.

    Am J Surg. 2012 Jun;203(6):761-7. Epub 2011 Dec 16.

    PMID:
    22178481
    [PubMed - in process]
    2.

    Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma.

    Chai CY, Zager JS, Szabunio MM, Marzban SS, Chau A, Rossi RM, Sondak VK.

    Ann Surg Oncol. 2012 Apr;19(4):1100-6. Epub 2011 Dec 23.

    PMID:
    22193886
    [PubMed - in process]
    3.

    Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.

    Yang GB, Barnholtz-Sloan JS, Chen Y, Bordeaux JS.

    Arch Dermatol. 2011 Dec;147(12):1395-402.

    PMID:
    22184761
    [PubMed - indexed for MEDLINE]
    4.

    Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.

    Inoh Y, Furuno T, Hirashima N, Kitamoto D, Nakanishi M.

    Biochem Biophys Res Commun. 2011 Oct 28;414(3):635-40. Epub 2011 Oct 6.

    PMID:
    22001930
    [PubMed - indexed for MEDLINE]
    5.

    Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review.

    Durbec F, Martin L, Derancourt C, Grange F.

    Br J Dermatol. 2012 Apr;166(4):727-39. doi: 10.1111/j.1365-2133.2011.10772.x.

    PMID:
    22175696
    [PubMed - in process]
    6.

    NRAS mutation status is an independent prognostic factor in metastatic melanoma.

    Jakob JA, Bassett RL Jr, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA.

    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26724. [Epub ahead of print]

    PMID:
    22180178
    [PubMed - as supplied by publisher]
    7.

    Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination.

    Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC.

    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26707. [Epub ahead of print]

    PMID:
    22179848
    [PubMed - as supplied by publisher]
    8.

    Examining the pathways linking lower socioeconomic status and advanced melanoma.

    Pollitt RA, Swetter SM, Johnson TM, Patil P, Geller AC.

    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26706. [Epub ahead of print]

    PMID:
    22179775
    [PubMed - as supplied by publisher]
    9.

    SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells.

    Liu KS, Liu H, Qi JH, Liu QY, Liu Z, Xia M, Xing GW, Wang SX, Wang YF.

    Cancer Lett. 2012 May 28;318(2):180-8. doi: 10.1016/j.canlet.2011.12.015. Epub 2011 Dec 17.

    PMID:
    22182451
    [PubMed - indexed for MEDLINE]
    10.

    Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.

    Muraki C, Ohga N, Hida Y, Nishihara H, Kato Y, Tsuchiya K, Matsuda K, Totsuka Y, Shindoh M, Hida K.

    Int J Cancer. 2012 Jan 1;130(1):59-70. doi: 10.1002/ijc.25976. Epub 2011 Apr 20.

    PMID:
    21384343
    [PubMed - indexed for MEDLINE]
    11.

    Sun-protection behaviors of melanoma survivors.

    Mayer D, Layman A, Carlson J.

    J Am Acad Dermatol. 2012 Jan;66(1):e9-10. No abstract available.

    PMID:
    22177654
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    A definitive case of metastatic folliculotropic melanoma.

    Davis M, Brennan CB, Mullins SC, Sheehan D.

    J Am Acad Dermatol. 2012 Jan;66(1):159-60. No abstract available.

    PMID:
    22177638
    [PubMed - indexed for MEDLINE]
    13.

    Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma.

    Tarhini AA, Cherian J, Moschos SJ, Tawbi HA, Shuai Y, Gooding WE, Sander C, Kirkwood JM.

    J Clin Oncol. 2012 Jan 20;30(3):322-8. Epub 2011 Dec 19.

    PMID:
    22184371
    [PubMed - indexed for MEDLINE]
    14.

    Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.

    Fujimura T, Ring S, Umansky V, Mahnke K, Enk AH.

    J Invest Dermatol. 2012 Apr;132(4):1239-46. doi: 10.1038/jid.2011.416. Epub 2011 Dec 22.

    PMID:
    22189788
    [PubMed - indexed for MEDLINE]
    15.

    The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.

    Barr J, Amato CM, Robinson SE, Kounalakis N, Robinson WA.

    Melanoma Res. 2012 Feb;22(1):92-5.

    PMID:
    22189301
    [PubMed - in process]
    16.

    Vemurafenib for melanoma metastases to the brain.

    Rochet NM, Kottschade LA, Markovic SN.

    N Engl J Med. 2011 Dec 22;365(25):2439-41. No abstract available.

    PMID:
    22188003
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Error occurred: cannot get document summary

    PMID:
    22193402

    18.

    Novel cancer immunotherapy agents with survival benefit: recent successes and next steps.

    Sharma P, Wagner K, Wolchok JD, Allison JP.

    Nat Rev Cancer. 2011 Oct 24;11(11):805-12. doi: 10.1038/nrc3153. Review.

    PMID:
    22020206
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk